Dark Clouds Looming Over Regenerative Medicine in Japan
Japan's regenerative medicine sector has encountered major challenges, underscored by the recent failures of products such as HeartSheet and Collategene. These setbacks expose critical weaknesses in the fast-track approval system, raising concerns about patient safety and the scientific robustness of product evaluations. Despite strong governmental support, addressing these fundamental issues is essential for the future success of regenerative medicine in Japan.
Authors
- Hiroshi Kawaguchi (ORCID: https://orcid.org/0000-0001-7091-4324)
Institutions
- Nadogaya Hospital (JP)
Publication Details
- Journal
- Stem Cells and Development
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1089/scd.2025.0012
- Citations
- 1
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.16